DOMINION DIAGNOSTICS LLC NPI 1912903717

NPI Details

DOMINION DIAGNOSTICS, LLC is a clinical medical laboratory in North Kingstown, RI. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. DOMINION DIAGNOSTICS, LLC NPI is 1912903717. The provider is registered as an organization entity type.

The provider's business location address is:

211 CIRCUIT DRIVE
NORTH KINGSTOWN, RI
ZIP 02852-440
Phone: (877) 734-9600
Fax: (401) 667-0330

The provider's authorized official is Brandy Ellis .
The authorized official title is Payer Relations Rep and has the following contact phone number (802) 734-6392.

The CLIA number assigned to this NPI record is 49D0926092 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Urine pregnancy test (HCPCS:81025)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Prolactin (milk producing hormone) level (HCPCS:84146)
• Hemoglobin a1c level (HCPCS:83036)
• Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
• Hepatitis c antibody measurement (HCPCS:86803)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Valproic acid level, total (HCPCS:80164)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Vitamin d-3 level (HCPCS:82306)
• Syphilis detection test (HCPCS:86592)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Detection test by nucleic acid for hepatitis c virus, quantification (HCPCS:87522)
• Automated urinalysis test (HCPCS:81003)
• Magnesium level (HCPCS:83735)
• Lithium level (HCPCS:80178)
• Bilirubin level, direct (HCPCS:82248)
• Folic acid level, serum (HCPCS:82746)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Measurement of hepatitis a antibody (HCPCS:86708)
• Tuberculosis test, enumeration of t-cells (HCPCS:86481)
• Homocysteine (amino acid) level (HCPCS:83090)
• Bacterial colony count, urine (HCPCS:87086)
• Detection test by immunoassay technique for hepatitis b surface antigen neutralization (HCPCS:87341)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Measurement of hepatitis a antibody (igm) (HCPCS:86709)

The enumeration date for this NPI number is 6/27/2005 and was last updated on 12/14/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.